These data indicate that PD-1 expression identifies tumor-reactive peripheral blood CD8+ T cells, indicating that expression of PD-1 after ex vivo expansion may be used to prospectively identify and select a repertoire of CD8+ tumor-reactive cells. This evidence concerns the gene CD8A and neoplasm.